Sprint Bioscience is an innovative company focused on early-stage drug development, providing novel drug candidates within the cancer field.
Looking for a particular Sprint Bioscience employee's phone or email?
The Sprint Bioscience annual revenue was $1 million in 2026.
Johan Emilsson is the CEO of Sprint Bioscience.
33 people are employed at Sprint Bioscience.
The NAICS codes for Sprint Bioscience are [5417, 541, 541714, 54, 54171].
The SIC codes for Sprint Bioscience are [87, 873].